Galaxy Therapeutics Secures CE Mark for SEAL System
Milpitas, California, August 4, 2026 Galaxy Therapeutics has announced that its SEAL™ Embolization System has received CE Mark certification...
FDA PMA
Advertisement
CereVasc Completes Pivotal STRIDE Trial Enrollment for eShunt
BOSTON, June 23, 2026 CereVasc, Inc. has completed patient enrollment in its pivotal STRIDE clinical trial, marking a major...
Guided Therapeutics Advances FDA Review of LuViva Cervical Cancer Screening Technology
PEACHTREE CORNERS, Ga., June 2026 Guided Therapeutics, Inc. announced the submission of its Premarket Approval (PMA) clinical report to...
Galaxy Therapeutics Submits PMA for SEAL Device FDA
MILPITAS, CALIFORNIA, April 27, 2026 Galaxy Therapeutics has announced the submission of the final module of its Premarket Approval...
Acclaim Cochlear Implant Trial Nears Full Enrollment
WHITE BEAR LAKE, MINNESOTA, UNITED STATES — February 17, 2026 Envoy Medical announced that enrollment in its pivotal clinical...
Advertisement
